Home › Research › Health systems and care delivery
Additional file 1 of National trends in the prevalence of dementia in Medicare Advantage and Traditional Medicare
Mauricio Lopez-Mendez, David J. Meyers, Victoria Shier, E Jutkowitz. Figshare, 2026-03-07
Topic: Risk, prevention and care in population studies
Plain-language summary
We do not hold a plain-English summary of this study yet. Use the links to the original below for its abstract and findings.
What this study adds
Evidence grade: Low
This entry is only supplementary material with no summary or key findings provided. No information is available to describe what it means for treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lopez-Mendez, M., Meyers, D. J., Shier, V., & Jutkowitz, E. (2026). Additional file 1 of National trends in the prevalence of dementia in Medicare Advantage and Traditional Medicare. Figshare. https://doi.org/10.6084/m9.figshare.32016613
Vancouver
Lopez-Mendez M, Meyers DJ, Shier V, Jutkowitz E. Additional file 1 of National trends in the prevalence of dementia in Medicare Advantage and Traditional Medicare. Figshare. 2026. doi:10.6084/m9.figshare.32016613.
BibTeX
@article{lopezmendez2026-073e5f43,
author = {Lopez-Mendez, Mauricio and Meyers, David J. and Shier, Victoria and Jutkowitz, E},
title = {{Additional file 1 of National trends in the prevalence of dementia in Medicare Advantage and Traditional Medicare}},
journal = {Figshare},
year = {2026},
doi = {10.6084/m9.figshare.32016613},
url = {https://doi.org/10.6084/m9.figshare.32016613}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Why it matters
This entry is only supplementary material with no summary or key findings provided. No information is available to describe what it means for treating, curing or preventing Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 33/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record and senior author's track record, so those were left out: it earned 30 of the 92 points we could judge it on, which is 33 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Figshare) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author E Jutkowitz holds only 4 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 2 / 3 | University of Southern California: institution h-index 1,521 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 30 / 92 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 30 of the 92 points we could judge it on is 33 out of 100. |
| Total | 33 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Health systems and care delivery from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.